AEGON Asset Management (UK)’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9M Buy
107,888
+17,283
+19% +$3.39M 0.24% 84
2026
Q1
$17.8M Hold
90,605
0.24% 96
2025
Q4
$15.7M Sell
90,605
-27,786
-23% -$5.06M 0.19% 103
2025
Q3
$22.6M Hold
118,391
0.27% 88
2025
Q2
$21.2M Sell
118,391
-24,222
-17% -$4.21M 0.27% 86
2025
Q1
$24.1M Sell
142,613
-2,160
-1% -$355K 0.35% 75
2024
Q4
$21.9M Buy
144,773
+15,475
+12% +$2.41M 0.29% 88
2024
Q3
$20.1M Buy
129,298
+1,343
+1% +$201K 0.27% 91
2024
Q2
$17.5M Sell
127,955
-100,694
-44% -$13.8M 0.25% 93
2024
Q1
$30.4M Buy
228,649
+4,715
+2% +$612K 0.46% 57
2023
Q4
$30.9M Buy
+223,934
New +$29.4M 0.49% 58
2023
Q2
$40.7M Sell
289,847
-860
-0.3% -$119K 0.66% 43
2023
Q1
$41.1M Buy
290,707
+19,891
+7% +$2.85M 0.72% 47
2022
Q4
$42.4M Buy
+270,816
New +$38.9M 0.77% 47
2017
Q3
Sell
-6,947
Closed -$772K 180
2017
Q2
$772K Sell
6,947
-213
-3% -$22.5K 0.02% 190
2017
Q1
$703K Sell
7,160
-3,196
-31% -$305K 0.02% 213
2016
Q4
$952K Sell
10,356
-547
-5% -$47.1K 0.03% 172
2016
Q3
$922K Buy
+10,903
New +$916K 0.03% 171

Other funds holding DGX

AEGON Asset Management (UK)'s DGX Position: Q2 2026 in Review

AEGON Asset Management (UK) increased its Quest Diagnostics (DGX) stake by 19% in Q2 2026, buying an estimated $3.39M and bringing the position to 107,888 shares worth $22.9M. The position accounts for 0.24% of the portfolio, ranked #84.

AEGON Asset Management (UK) first reported a position in DGX in Q3 2016 and has held it in 18 quarters since. The position peaked at $42.4M in Q4 2022. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • AEGON Asset Management (UK) held 107,888 shares of Quest Diagnostics worth $22.9M as of Q2 2026.
  • AEGON Asset Management (UK) bought 17,283 Quest Diagnostics shares in Q2 2026, an estimated $3.39M.
  • Quest Diagnostics made up 0.24% of AEGON Asset Management (UK)'s portfolio in Q2 2026, its #84 holding.
  • AEGON Asset Management (UK) first reported a position in Quest Diagnostics in Q3 2016 and has held it in 18 quarters since.
  • AEGON Asset Management (UK)'s Quest Diagnostics position peaked at $42.4M in Q4 2022.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on AEGON Asset Management (UK)'s 13F filing for Q2 2026, filed 13 Jul 2026.